Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Expert Review of Vaccines

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14760584.3.4.S119PMID 15285711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.

  2005cited by this paper
• Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.

  2004cited by this paper
• The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function

  2004cited by this paper
• Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

  2004cited by this paper
• Enteral Immunization with Attenuated Recombinant Listeria monocytogenes as a Live Vaccine Vector: Organ-Dependent Dynamics of CD4 T Lymphocytes Reactive to a Leishmania major Tracer Epitope

  2003cited by this paper
• The discovery of HIV as the cause of AIDS.

  2003cited by this paper
• The Induction of HIV Gag-Specific CD8+ T Cells in the Spleen and Gut-Associated Lymphoid Tissue by Parenteral or Mucosal Immunization with Recombinant Listeria monocytogenes HIV Gag1

  2003cited by this paper
• Tailoring host immune responses to Listeria by manipulation of virulence genes -- the interface between innate and acquired immunity.

  2003cited by this paper
• Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.

  2003cited by this paper
• Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery

  2003cited by this paper
• Protection of interferon-gamma knockout mice against Listeria monocytogenes challenge following intramuscular immunization with DNA vaccines encoding listeriolysin O.

  2003cited by this paper
• Safety and Immunogenicity in Neonatal Mice of a Hyperattenuated Listeria Vaccine Directed against Human Immunodeficiency Virus

  2002cited by this paper
• Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

  2002cited by this paper
• Safety and Shedding of an Attenuated Strain of Listeria monocytogenes with a Deletion of actA/plcB in Adult Volunteers: a Dose Escalation Study of Oral Inoculation

  2002cited by this paper
• Chronic bacterial infections: living with unwanted guests

  2002cited by this paper
• Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection.

  2002cited by this paper
• Cutaneous Complications of BCG Vaccination in Infants with Immune Disorders: Two Cases and a Review of the Literature

  2001cited by this paper
• Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.

  2001cited by this paper
• Intracellular antibody neutralizes Listeria growth.

  2001cited by this paper
• Vaccination Strategies for Mucosal Immune Responses

  2001cited by this paper
• A Transgenic Model for Listeriosis: Role of Internalin in Crossing the Intestinal Barrier

  2001cited by this paper
• Systemic Immunity and Mucosal Immunity Are Induced against Human Immunodeficiency Virus Gag Protein in Mice by a New Hyperattenuated Strain of Listeria monocytogenes

  2001cited by this paper
• Gut Colonization of Mice withactA-Negative Mutant of Listeria monocytogenesCan Stimulate a Humoral Mucosal Immune Response

  2001cited by this paper
• Identification of New Genes Involved in the Virulence of Listeria monocytogenes by Signature-Tagged Transposon Mutagenesis

  2001cited by this paper
• Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-161

  2001cited by this paper
• D-Amino Acids as Putative Neurotransmitters: Focus on D-Serine

  2000cited by this paper
• Listeria monocytogenes as a Short-Lived Delivery System for the Induction of Type 1 Cell-Mediated Immunity against the p36/LACK Antigen of Leishmania major

  2000cited by this paper
• InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase

  2000cited by this paper
• Induction of Human Immunodeficiency Virus (HIV)-Specific CD8 T-Cell Responses by Listeria monocytogenes and a Hyperattenuated Listeria Strain Engineered To Express HIV Antigens

  2000cited by this paper
• Ethical issues in tuberculosis vaccine trials.

  2000cited by this paper
• Adaptive Immunity and Enhanced CD8+ T Cell Response to Listeria monocytogenes in the Absence of Perforin and IFN-γ1

  2000cited by this paper
• HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1

  2000cited by this paper
• InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase.

  2000cited by this paper
• Interactions between Listeria monocytogenes and host mammalian cells.

  2000cited by this paper
• Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection.

  1999cited by this paper
• Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine.

  1999cited by this paper
• Existing Antilisterial Immunity Does Not Inhibit the Development of a Listeria monocytogenes-Specific Primary Cytotoxic T-Lymphocyte Response

  1999cited by this paper
• The mucosal phase of Listeria infection.

  1999cited by this paper
• Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.

  1999cited by this paper
• Cytotoxic T lymphocytes, chemokines and antiviral immunity.

  1999cited by this paper
• Pathogenicity and Immunogenicity of aListeria monocytogenes Strain That Requiresd-Alanine for Growth

  1998cited by this paper
• Fully mobilizing host defense: Building better vaccines

  1998cited by this paper
• The role of cytotoxic T-cells in HIV infection.

  1998cited by this paper
• Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.

  1998cited by this paper
• Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

  1998cited by this paper
• The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.

  1998cited by this paper
• Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

  1998cited by this paper
• Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

  1998cited by this paper
• Attenuated Listeria monocytogenescarrier strains can deliver an HIV‐1 gp120 T helper epitope to MHC class II‐restricted human CD4+ T cells

  1998cited by this paper
• Host susceptibility factors to cutaneous leishmaniasis.

  1998cited by this paper
• An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk.

  1997cited by this paper
• Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease

  1997cited by this paper
• Co‐evolution of human immunodeficiency virus and cytotoxic T‐lymphocyte responses

  1997cited by this paper
• Listeriosis.

  1997cited by this paper
• Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell‐mediated immunity

  1997cited by this paper
• Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

  1997cited by this paper
• Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA

  1997cited by this paper
• Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.

  1997cited by this paper
• Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1

  1997cited by this paper
• The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

  1997cited by this paper
• The defined attenuated Listeria monocytogenes Δmpl2 mutant is an effective oral vaccine carrier to trigger a long‐lasting immune response against a mouse fibrosarcoma

  1997cited by this paper
• Role of cellular immunity in protection against HIV infection.

  1997cited by this paper
• A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

  1995cited by this paper
• Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine.

  1995cited by this paper
• Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.

  1995cited by this paper
• Reexamining AIDS research priorities

  1995cited by this paper
• Specific immunity to Listeria monocytogenes in the absence of IFN gamma.

  1995cited by this paper
• Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

  1995cited by this paper
• Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus.

  1995cited by this paper
• Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity.

  1995cited by this paper
• Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.

  1994cited by this paper
• Pathogenic diversity of simian immunodeficiency viruses.

  1994cited by this paper
• Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

  1994cited by this paper
• Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes

  1994cited by this paper
• Pathogenesis of human immunodeficiency virus infection

  1993cited by this paper
• SALMONELLA SEPSIS AND SECOND‐TRIMESTER PREGNANCY LOSS

  1992cited by this paper
• Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.

  1992cited by this paper
• Immunity to intracellular bacteria.

  1992cited by this paper
• Molecular determinants of Listeria monocytogenes pathogenesis

  1992cited by this paper
• Listeria monocytogenes, a Food-Borne Pathogen

  1991cited by this paper
• Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.

  1990cited by this paper
• The immunological principles of vaccination.

  1990cited by this paper
• Bacterial Infections of Nonhuman Primates

  1986cited by this paper
• A review of human salmonellosis: I. Infective dose.

  1982cited by this paper
• Immunity to intracellular bacteria.

  1982cited by this paper
• Septicemia and Meningoencephalitis Caused by Listeria monocytogenes in a Neonatal Macaca fascicularis

  1981cited by this paper
• Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

  1978cited by this paper
• CELLULAR RESISTANCE TO INFECTION

  1962cited by this paper

• Identification and evaluation of a panel of strong constitutive promoters in Listeria monocytogenes for improving the expression of foreign antigens

  2021cites this paper
• The development of gene-based vectors for immunization

  2020cites this paper
• Listeria Monocytogenes: A Model Pathogen Continues to Refine Our Knowledge of the CD8 T Cell Response

  2018cites this paper
• Mobilising a global response to hepatitis: Lessons learned from the HIV movement

  2018cites this paper
• Development of Gene-Based Vectors for Immunization

  2017cites this paper
• HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies

  2015cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• Live-attenuated bacteria as a cancer vaccine vector

  2013cites this paper
• Bacterial vectors for active immunotherapy reach clinical and industrial stages

  2012cites this paper
• In Vitro Properties of a Listeria monocytogenes Bacteriophage-Resistant Mutant Predict Its Efficacy as a Live Oral Vaccine Strain

  2011cites this paper
• Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

  2010cites this paper
• Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites.

  2010cites this paper
• Cytotoxic T‐lymphocyte antigen 4 blockade augments the T‐cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge

  2009cites this paper
• Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C.

  2009cites this paper
• Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

  2009cites this paper
• Imaging Listeria monocytogenes infection in vivo.

  2009cites this paper
• Anti-Infective Vaccine Strategies

  2008cites this paper
• Selected prfA* Mutations in Recombinant Attenuated Listeria monocytogenes Strains Augment Expression of Foreign Immunogens and Enhance Vaccine-Elicited Humoral and Cellular Immune Responses

  2008cites this paper
• Listeria monocytogenes as novel carrier system for the development of live vaccines.

  2008cites this paper
• Cellular Immune Responses Immunogens and Enhance Vaccine-Elicited Strains Augment Expression of Foreign Listeria monocytogenes Attenuated * Mutations in Recombinant prfA Selected

  2008cites this paper
• Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

  2007cites this paper
• Macaques co‐immunized with SIVgag/pol‐HIVenv and IL‐12 plasmid have increased cellular responses

  2007cites this paper
• The PrfA virulence regulon.

  2007cites this paper
• Listeria as a vaccine vector.

  2007cites this paper
• A 20-Year Perspective on Listeria monocytogenes Pathogenesis

  2007cites this paper
• Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.

  2006cites this paper
• A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.

  2006cites this paper
• The protein secretion systems in Listeria: inside out bacterial virulence.

  2006cites this paper
• Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy

  2006cites this paper
• Subdominant Epitopes in the FVB/N Mouse Immunogenicity of HER-2/neu and Reveals Enhances the Listeria monocytogenes Fusion to Listeriolysin O and Delivery by

  2005cites this paper
• Fusion to Listeriolysin O and Delivery by Listeria monocytogenes Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse1

  2005cites this paper
• SIV DNA vaccine co‐administered with IL‐12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

  2005cites this paper